Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition containing ubiquitin-like modified protein and application thereof

A ubiquitin-like and protein-like technology, applied in the field of biomedicine, can solve problems such as unclear mechanisms, and achieve the effects of promoting the growth of neuron axons, increasing the level of microtubule cutting, and promoting repair

Active Publication Date: 2021-09-24
JINAN UNIVERSITY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The specific mechanism by which Katanin regulates neurons has not yet been clarified, although a small number of studies have found that Katanin may be modified by ubiquitinated proteins to regulate the growth of neuronal processes, but the specific mechanism is still unclear, and whether Katanin is also regulated by other types of modifications, and is even more ignorant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing ubiquitin-like modified protein and application thereof
  • Pharmaceutical composition containing ubiquitin-like modified protein and application thereof
  • Pharmaceutical composition containing ubiquitin-like modified protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1 Ubiquitin-like modification of Katanin p60

[0054] (1) Construct GST-SUMO1, GST-SUMO2, and GST-SUMO3 plasmids, and transform the constructed plasmids into competent BL21 cells;

[0055] (2) After overnight culture, select monoclonal positive colonies and verify that they are correct, then take 3 mL of the bacterial liquid and culture it in 250 mL of LB medium containing 1% ampicillin resistance, in a shaker at 37°C, 180 rpm, until the OD of the bacterial liquid is 0.8;

[0056] (3) Add 0.1mM IPTG to induce at 30°C for 6-8h;

[0057] (4) Collect the bacterial liquid at 4°C, 12000 rpm, add an appropriate amount of lysate, bathe in ice for 1 hour, oscillate several times every 15 minutes, use an ultrasonic breaker with 20% intensity, 5s×5s, and sonicate 6 times;

[0058] (5) Centrifuge at 12,000 rpm for 15 minutes at 4°C to take the turbid supernatant from the upper layer;

[0059] (6) Add 200 μL beads to the centrifuge tube, add 1 mL of lysate, remove the sup...

Embodiment 2

[0072] Example 2 Co-localization of Katanin p60 and SUMO2 protein

[0073] (1) Culture hippocampal neuron cells, fix with 4% PFA at 4°C for 40 min, and wash with pre-cooled PBS;

[0074] (2) Drill holes with TBST (containing 1% Triton X-100) at room temperature (add 500 μL of cells to each well), 5 min / time, repeat twice;

[0075] (3) Prepare 3% blocking serum (0.3g BSA+10mL TBST), add 200μL blocking serum to each well of cells, and block for 1h at room temperature;

[0076] (4) Transfer the Coverlips to the antibody incubation box, with the cell-containing slide facing up, wash with TBST, add the antibody to the blocking serum for dilution, add 60 μL of the mixed dilution of Katanin p60 antibody and SUMO2 antibody to each Coverlips, and incubate at 4°C overnight;

[0077] (5) After recovering the mixed diluent of Katanin p60 antibody and SUMO2 antibody incubated in step (4), wash with TBST, add secondary antibody and blocking serum, add 60 μL of antibody diluent to each Cov...

Embodiment 3

[0081] Example 3 Effect of Katanin p60 mutant on microtubule cutting function

[0082] (1) Construct GFP-Katanin p60 plasmid (NCBI Reference Sequence: NP_001004217.2);

[0083] (2) Through bioinformatics software analysis, three potential SUMOylation sites in Katanin p60 were determined, namely K77, K157 and K330 (see Figure 4 );

[0084] (3) For the three sites K77, K157 and K330, perform site mutations on the GFP-Katanin p60 plasmid constructed in step (1) to obtain GFP-Katanin p60-K77R, GFP-Katanin p60-K157R, and GFP-Katanin p60-K330R and PAN with three simultaneous mutations;

[0085] (4) After COS7 cells were treated with 10mM Tubacin, COS7 cells were transfected with GFF, the GFP-Katanin p60 plasmid constructed in step (1) and the mutant plasmid obtained in step (3);

[0086](5) Observe the changes of Tubulin by immunofluorescence chemical staining.

[0087] The inventors of the present invention found that Katanin p60 has the ability to cut microtubules, especially...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition containing ubiquitin-like modified protein and its application. The present invention has discovered that Katanin p60 can be modified by SUMOylation. After SUMO modification, the microtubule cutting level of Katanin p60 can be significantly increased, the growth of neuron axons can be promoted, and the repair of spinal cord injury can be promoted; the process of SUMOylated modification of Katanin p60 In-depth research on the potential key sites in the body, it is clear that Katanin p60 is a key protein that performs the function of microtubule cutting, and it can be modified by SUMOylation, and SUMOylation modification can significantly enhance the ability of Katanin p60 to cut microtubules; the present invention fully Revealed the role of Katanin p60 SUMOylation in the process of neuronal axon growth and spinal cord injury repair, affirmed the phenomenon of Katanin p60 ubiquitination-like modification, clarified the key sites mediating the modification, revealed The new mechanism of SUMOylation of Katanin p60 to regulate the growth of neuron axons provides practical experimental evidence and scientific basis for the clinical treatment of spinal cord injury.

Description

technical field [0001] The invention belongs to the field of biomedicine, and relates to a pharmaceutical composition containing ubiquitination-modified protein and its application, in particular to a pharmaceutical composition containing ubiquitination-modified protein for promoting the growth of neuron axons and repairing spinal cord injury pharmaceutical composition and its application. Background technique [0002] At present, the repair of spinal cord injury is one of the worldwide problems. The key to the repair of spinal cord injury is axon regeneration. Now how to regenerate damaged axons has become a scientific hotspot. Neuronal cells are highly differentiated cells, so their plasticity is very limited, and regeneration of the adult mammalian central nervous system, including the spinal cord, is difficult. At present, the means of promoting partial regeneration of axons by improving the microenvironment around the damaged axons include Rho-ROC inhibition, anti-NOGO...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/45A61K47/62A61P25/00
CPCA61K38/45A61K47/62A61P25/00
Inventor 谭明会林宏生李少劲张国威梁耀中蔡振彬邹健宇梁志杨杰
Owner JINAN UNIVERSITY